TRPA1 and chronic obstructive pulmonary disease: Thus, this paper paves the way for further studies (e.g., a prospective virtual screening) in search of new potential TRPA1 antagonists in the group of xanthine derivatives as well as their bioisosteres, and hence potential new drugs for the treatment of neuropathic pain, asthma, and COPD.